Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,148 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06504940RecruitingPhase 2
Study of orelabrutinib plus BR or G for untreated marginal zone lymphoma
This trial tests a combination of targeted therapy (orelabrutinib) plus chemotherapy (BR) or antibody therapy (G) for people with untreated marginal zone lymphoma. It aims to see if this combination can help patients who haven't had treatment yet.
Hangzhou, ZhejiangAges 18 years+ - NCT06503367Recruiting
Observation study for children 0-5 with LAMA2 muscular dystrophy
This study follows young children with LAMA2-related congenital muscular dystrophy to learn more about the disease. It does not test a new treatment, so it may help families understand the condition better and prepare for future trials.
Los Angeles, CaliforniaAges Up to 5 years - NCT06503302Recruiting
Ultrasound effect on calcified shoulder tendinitis
This trial tests if using Doppler ultrasound to guide treatment can help people with long-term shoulder pain caused by calcified deposits. It may offer a more targeted way to relieve pain.
TaipeiAges 18–80 - NCT06500104Enrolling by invitation
Kefir for Childhood Obesity: A Trial
This trial tests whether a probiotic drink called kefir (a fermented milk beverage) can help children and teens with obesity lose weight or improve their health. It's for children who are significantly above a healthy weight and don't have other serious medical conditions or dairy allergies.
TaichungAges 7–17 - NCT06509022Enrolling by invitation
Reflux study after esophageal cancer surgery
This study is for people who have had surgery for esophageal cancer. It uses a special test called PEPTEST to track acid reflux after surgery and find out what affects it.
BeijingAges Any age - NCT06496373RecruitingEarly Phase 1
mRNA vaccine plus immunotherapy after pancreatic cancer surgery
This trial tests a personalized mRNA vaccine combined with an immunotherapy drug (PD-1 inhibitor) to prevent pancreatic cancer from returning after surgery. It is for patients whose tumors have specific genetic features and who cannot have standard chemotherapy.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06506448Recruiting
Studying non-blocked arteries after a heart attack
This study looks at arteries in the heart that aren't the one that caused the heart attack. It uses a special CT scan to understand these arteries better in people who have already had a procedure to open the blocked artery.
Bournemouth, DorsetAges 18–85 - NCT06497959RecruitingPhase 3
Ultrasound study of placenta blood flow
This trial uses a special contrast dye during ultrasound to examine blood flow in the placenta of pregnant women who have chosen to end their pregnancy for medical reasons. It may help understand the role of poor placental blood flow in severe fetal growth restriction.
NancyAges 18–64 - NCT06502015Recruiting
Biomarkers in nervous system autoimmune diseases
This study looks for biomarkers (biological clues) in people with autoimmune diseases of the nervous system. It aims to discover better ways to diagnose and treat these conditions.
WuhanAges 18 years+ - NCT06511232RecruitingPhase 4
Morphine in bone for ACL surgery pain
This trial tests if giving morphine directly into the bone during ACL reconstruction can reduce pain after surgery. It may help patients who are having a specific type of ACL repair using their own patellar tendon.
Houston, TexasAges 18–40 - NCT06481644Recruiting
Study of kids in Asian pediatric ICUs
This study looks at children admitted to pediatric intensive care units (ICUs) in Asia to understand their health patterns and outcomes. It may help improve care for future patients.
SingaporeAges Any age - NCT06482983Recruiting
Two breathing methods for women having laparoscopic gynecologic surgery
This study compares two ways of helping you breathe during surgery to see which one is better for your brain and lungs. The results may help doctors choose the safest method for people like you.
Istanbul, UmraniyeAges 18–70 - NCT06244537Recruiting
MR-Linac radiation for advanced colon cancer
This trial tests a new radiation machine called MR-Linac for people with advanced colon cancer that cannot be removed by surgery. The goal is to see if it is safe and works well.
Chengdu, SichuanAges 18 years+ - NCT06495515RecruitingPhase 2
Dalpiciclib plus toremifene for advanced HR+ breast cancer
This trial tests a combination of two drugs (dalpiciclib and toremifene) as a first treatment for advanced breast cancer that is hormone receptor positive and HER2 negative. It may be an option if you have not had hormone therapy for advanced disease or if your cancer came back more than a year after prior treatments.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06480370Recruiting
Optimizing brain monitoring during surgery
This trial tests a way to improve how signals from the brain are monitored during surgery to protect important areas. It might help ensure the surgery is safer and more precise.
BernAges 18 years+ - NCT06491030RecruitingPhase 4
Brace use after spinal fusion for adults with spine curves
This trial tests whether wearing a back brace after surgery helps prevent problems at the top of a spinal fusion. It is for adults aged 30-75 having their first spine fusion from near the middle of the back down to the tailbone or pelvis.
Carmel, IndianaAges 30–75 - NCT06492785Recruiting
Hyaluronic acid in embryo transfer for better success
This trial tests whether adding hyaluronic acid to the fluid used during embryo transfer helps more embryos implant, leading to a successful pregnancy. It's for people having a single embryo transfer with their own eggs.
Xi'an, ShaanxiAges Any age - NCT06494488RecruitingEarly Phase 1
Testing how omega-3s affect heart health and blood clotting
This study tests whether two types of omega-3s (EPA and DHA) help improve HDL (good cholesterol) and reduce blood clot risk in people with high triglycerides and low HDL cholesterol.
Providence, Rhode IslandAges 18–69 - NCT06485336RecruitingPhase 2
Atorvastatin for prevention of chronic migraine
This trial tests whether the cholesterol drug atorvastatin can reduce the number of migraine days in people with chronic migraine (15 or more headache days per month, including at least 8 migraine days). If you have frequent migraines and haven't tried statins before, this study may offer a new preventive option.
BergenAges 18–65 - NCT06488638Recruiting
Beetroot juice supplement for lung fibrosis
This trial tests whether a beetroot juice drink (rich in nitrates) can help people with idiopathic pulmonary fibrosis breathe better and exercise more. It's a small pilot study to see if it's safe and worth studying further.
SouthamptonAges 18–85 - NCT06483906RecruitingPhase 2
Study of a drug combo and stem cell transplant for high-risk AML
This trial tests a combination of three drugs (venetoclax, azacitidine, and homoharringtonine) followed by a donor stem cell transplant for people with intermediate- or high-risk acute myeloid leukemia (AML). The goal is to see if this approach can improve outcomes for patients who have not been treated before.
Shanghai, Shanghai MunicipalityAges 18–55 - NCT06484621Recruiting
Preventing weight regain after weight loss surgery with exercise
This study looks at whether increased physical activity can help prevent weight regain after weight loss surgery. It is for people who had gastric bypass or sleeve gastrectomy in the last 6–20 months and have regained less than 10% of their lost weight.
Hartford, ConnecticutAges 18–64 - NCT06484153RecruitingPhase 2
New drug combo for advanced colorectal cancer
This trial tests a new combination of three drugs—fruquintinib (a targeted therapy), pirfenidone (an anti-fibrotic drug), and an immunotherapy (anti-PD-1)—for people with advanced colorectal cancer that has not responded to at least two prior treatments. The goal is to see if this triple therapy can shrink tumors more effectively than current options.
Wuhan, HubeiAges 18–75 - NCT06491745Recruiting
Shock wave therapy for frozen shoulder
This study tests whether adding shock wave therapy to standard treatments (physical therapy and a corticosteroid injection) helps people with frozen shoulder recover faster. If you have significant shoulder stiffness and pain, you might benefit from this extra treatment.
TaipeiAges 20–80
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,148 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.